Author: FindKM

Categories
Resource Centre - Publications

Results Report 2022

When COVID-19 emerged in early 2020, the Global Fund took swift action to fight the pandemic and protect hard-won gains against HIV, tuberculosis (TB) and malaria. With the support of our generous donors, we have since awarded more than US$4.4 billion to help countries respond to the new virus, mitigate its impact on lifesaving HIV, TB and malaria services and make urgent improvements to health systems. While we were not able to prevent COVID-19 from having a massive impact on people living in low- and middle-income countries, including both the direct impact of the new virus and the reversal of hard-won gains against HIV, TB and malaria, it could have been much worse.

We saw the benefits of the interventions we made in 2021, with gains in key programmatic results across all three diseases. The Global Fund’s Results Report 2022 details how our partnership played a critical role in supporting countries and communities to respond to the pandemic and continue the progress in the fight against HIV, TB and malaria.

Download Report


Categories
Add Resources - Awareness & Advocacy Resource Centre - Publications

COVID-19: Make it the Last Pandemic

This page contains the documents published in May 2021 when the Panel’s main report, entitled COVID-19: Make it the Last Pandemic, was released. These include the main report, a summary, an evidence-based narrative report, background documents, a report reflecting voices heard in townhall meetings, and multimedia materials including videos. Also included on this page is a sample of global public reaction following the report’s release.

Download Report


Categories
Resource Centre - Publications

The Impact of COVID-19 On HIV, TB And Malaria Services and Systems For Health: A Snapshot from 502 Health Facilities across Africa and Asia

The impact of COVID-19 on HIV, TB and Malaria Services and Systems for Health: A snapshot from 502 health facilities across Africa and Asia.

Download Document


Categories
Resource Centre - Publications

Regional Roundtable meeting on ‘Access to COVID-19 Tools-Accelerator (ACT-A) diagnostics pillar’ in the WHO South-East Asia Region

Street scene outside the Lok Nayak Jai Prakash Narayan Hospital, Delhi.December 2017Photo credit: FIND / Ben Phillips

Regional Roundtable meeting on

‘Access to COVID-19 Tools-Accelerator (ACT-A)

diagnostics pillar’ in the
WHO South-East Asia Region

New Delhi, India, 24 August 2021

Download Report


Categories
Resource Centre - Publications

Information sheet: Diagnostics for COVID-19

COVID-19 Diagnostics are tests used to detect infection with the SARS-COV-2 virus.

Download Information Sheet: English

Download Information Sheet: French


Categories
Resource Centre - Publications

The Lancet Commission on diagnostics: transforming access to diagnostics

Diagnostics are an essential part of a well functioning and high-quality health system. Yet, almost half of the global population has little or no access to diagnostics. The COVID-19 pandemic has shown acutely that diagnostic capacity in a country is directly linked to the ability to respond to the pandemic with appropriate public health measures and to monitor emerging variants. There is an urgent need to strengthen diagnostics for future pandemic preparedness but also beyond pandemics. Diagnostics are central to an accurate diagnosis of communicable and non-communicable diseases, to guide therapy, monitor progress, and assess response to treatment. The Commission puts forward recommendations to accelerate and transform access to diagnostics globally.

Download Document


Categories
Featured Work - Quality Assurance & Policy Resource Centre - Policies

WHO policy brief: COVID-19 testing, 14 September 2022

Key points 

  • It remains critical for national programmes to continue to offer testing for COVID-19 in line with three main objectives: reduce morbidity and mortality through linkage to prompt care and treatment, reduce onward transmission and track the evolution of the epidemic and the virus itself.
  • Testing of suspected cases early in the disease course – especially among people at increased risk for hospitalization or severe COVID-19 – enables access to supportive care and COVID-19 therapeutics.
  • Confirming COVID-19 through testing for SARS-CoV-2 followed by isolation (and follow up of relevant contacts) can reduce transmission. At the population level, fluctuations in testing data can contribute to decisions on intensifying or relaxing public health and social measures.
  • WHO continues to recommend maintaining and strengthening COVID-19 surveillance, including use of sequencing, to monitor changes in epidemiological patterns, trends in morbidity and mortality, the burden of disease on health care capacity (health and care workers, hospitalizations and intensive care unit admissions) and the evolution and circulation of variants.

Download Document


Categories
Add Resources - Quality Assurance & Policy Resource Centre - Policies

The Global Fund Quality Assurance Policy for Diagnostic Products

Implementers of Global Fund-supported programs must ensure the diagnostic products they purchase meet our partnership’s quality standards.

Visit Website


Categories
Resource Centre - Policies

The Essential Role of Diagnostics in Global Health & Development

T7 Task Force Global health
Policy Brief

THE ESSENTIAL ROLE OF DIAGNOSTICS IN GLOBAL HEALTH & DEVELOPMENT

20.05.2022

Bill Rodriguez FIND, the global alliance for diagnostics Willo Brock FIND, the global alliance for diagnostics Karishma Saran FIND, the global alliance for diagnostics

Download Document


Categories
Featured Work - Procurement & Supply Management Related Resources Resource Centre - Reports

Update on the rollout of COVID-19 tools: a report from the ACT-A Tracking & Monitoring Task Force

This report is an outcome of the first meeting of the ACT-Accelerator Tracking and Monitoring Taskforce, held on 9th December 2022. This new taskforce – co-chaired by India and the United States – continues key elements of the work of the Facilitation Council and its working groups. The report includes an outcome statement by the Co-Chairs and provides a briefing on the current status of the rollout of COVID-19 tools, including what actions are needed in the short-term to accelerate the work of ACT-A agencies and partners.  

More information on the taskforce can be found here.

Download Document